Antoni Ribas

This profile gathers the share dealings of Antoni Ribas in Arcus Biosciences, Inc., where the filings describe the role as board member. Between 3 June 2021 and 11 June 2026, the trades on record add up to 7 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 12 June 2026 came the latest disclosure, a share grant in Arcus Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.